Leftover blood samples could unlock new medical discoveries

NCT ID NCT04364503

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Sequenom, Inc. Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study collects leftover blood or tissue samples and related health data from people who have already had lab tests at LabCorp. The goal is to build a large, de-identified resource that scientists can use for future research on pregnancy, cancer, and infectious diseases. Some participants may also be asked for additional samples or information if they give permission. No new treatments are being tested here—this is about gathering data to fuel future discoveries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer infectious disease neoplasm pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER INFECTIOUS DISEASE PREGNANCY RELATED

Contacts and locations

Show contact details

Locations

Labcorp

Los Angeles, California, 90064, United States
Labcorp

Burlington, North Carolina, 27215, United States
Labcorp

Research Triangle Park, North Carolina, 27709, United States
Labcorp - Cytogenetics

Research Triangle Park, North Carolina, 27709, United States
Labcorp - Esoterix

Englewood, Colorado, 80112, United States
Labcorp - Litholink

Itasca, Illinois, 60143, United States
Labcorp - Monogram Biosciences

South San Francisco, California, 94080, United States
Labcorp - Omniseq

Buffalo, New York, 14203, United States
Sequenom, Inc

San Diego, California, 92121, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.